Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$27,000.00
Building a 3D model to mimic the walls of the artery for anti-restenosis drug screening
EF 2024-25
Résumé
Building a 3D model of the human artery to screen drugs preventing artery re-narrowing after surgeryNarrowing of blood vessels can cause cardiac problems and even death. Globally, at least two million surgeries occur each year to reopen narrowed blood vessels by inserting a stent. Stents can help reduce symptoms but can also damage the blood vessels. There is at least a 10% chance of this damage resulting in the blood vessel re-narrowing. Drugs can be used in surgery to decrease the chances of blood vessels narrowing after surgery. However, these drugs cause side effects that delay the healing process. This issue persists because there are no good blood vessel models to screen for new and better drugs. I intend to build a 3D model that faithfully mimics a coronary artery to enable drug screening and find better options that decrease the burden on patients and the healthcare system. First, I will create a 3D model using cells from human arteries and test whether this model mimics the function of a real human artery. I will start by damaging the cells in our blood vessel model. I expect to see our model mirroring the real-life narrowing of blood vessels after stent insertion. I will then add a known drug used during stent surgery. I will test whether the drug prevents the blood vessel narrowing process in our model equal to its action during patient surgery. Our model should also display the negative side effects that the drug is known to have on artery healing. Our model will be a valuable and inexpensive tool for screening new drugs to reduce blood vessel re-narrowing. It will be more humane than animal testing and offer a first step towards predicting the action of these drugs on human arteries. This work has great potential to improve patient outcomes.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
530273
Name
Chatha Aakar
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Building a 3D model to mimic the walls of the artery for anti-restenosis drug screening
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
3d Modelling; Cell Crosstalk; Coronary Artery; Drug Screening; Endothelial Cells; Percutaneous Coronary Intervention; Rapamycin; Restenosis; Smooth Muscle Cells; Stenting
Abstract
Building a 3D model of the human artery to screen drugs preventing artery re-narrowing after surgeryNarrowing of blood vessels can cause cardiac problems and even death. Globally, at least two million surgeries occur each year to reopen narrowed blood vessels by inserting a stent. Stents can help reduce symptoms but can also damage the blood vessels. There is at least a 10% chance of this damage resulting in the blood vessel re-narrowing. Drugs can be used in surgery to decrease the chances of blood vessels narrowing after surgery. However, these drugs cause side effects that delay the healing process. This issue persists because there are no good blood vessel models to screen for new and better drugs. I intend to build a 3D model that faithfully mimics a coronary artery to enable drug screening and find better options that decrease the burden on patients and the healthcare system. First, I will create a 3D model using cells from human arteries and test whether this model mimics the function of a real human artery. I will start by damaging the cells in our blood vessel model. I expect to see our model mirroring the real-life narrowing of blood vessels after stent insertion. I will then add a known drug used during stent surgery. I will test whether the drug prevents the blood vessel narrowing process in our model equal to its action during patient surgery. Our model should also display the negative side effects that the drug is known to have on artery healing. Our model will be a valuable and inexpensive tool for screening new drugs to reduce blood vessel re-narrowing. It will be more humane than animal testing and offer a first step towards predicting the action of these drugs on human arteries. This work has great potential to improve patient outcomes.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chatha, Aakar
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~